Scientists test 'Smarter' transplant to fight blood cancers with fewer side effects
NCT ID NCT05088356
Summary
This early-stage trial is testing a new approach to stem cell transplants for adults with advanced blood cancers like leukemia. Researchers are modifying the donor cells by adding specific immune cells (regulatory T-cells) alongside the standard transplant. The goal is to help the patient's body fight the cancer while reducing a dangerous complication called graft-versus-host disease (GVHD), where donor cells attack the patient's healthy tissues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.